Risdiplam Decision Delayed Pending New SMA Data Review

The FDA has moved the PDUFA date for risdiplam back to August 24, 2020, as the agency works to review additional data that was made available from part 2 of the pivotal SUNFISH trial. 

Source link

Related posts

Myasthenic congenital myopathy from recessive mutations at a single residue in NaV1.4


Cognitive Decline Worsens With Memantine, ChEIs in Patients With Alzheimer's


Time to diagnosis and factors affecting diagnostic delay in amyotrophic lateral sclerosis


This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. Accept Read More

Privacy & Cookies Policy


COVID-19 (Coronavirus) is a new illness that is having a major effect on all businesses globally LIVE COVID-19 STATISTICS FOR World